PDE / ADE · OEL / OEB

Home→PDE/ADE · OEL/OEB Profiles → Insulin→

Insulin PDE report and OEL report profile

Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.

CAS Registry Number
9004-10-8
Molecular formula
C256H381N65O77S6
Molecular weight
5794 g/mol
Drug class
Peptide hormoneantidiabetic agent
Mechanism of action
Activates the insulin receptor tyrosine kinase, promoting peripheral glucose uptake (especially in skeletal muscle and adipose tissue) and inhibiting hepatic glucose production. It also inhibits lipolysis and proteolysis and promotes glycogen, lipid and protein synthesis.
Indications / reported uses
  • Treatment of diabetes mellitus, including type 1 diabetes and type 2 diabetes when insulin therapy is required.
  • Management of hyperglycaemia in selected acute-care settings with appropriate intravenous insulin formulations.

Sources: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b519bd83-038c-4ec5-a231-a51ec5cc291f · https://www.ncbi.nlm.nih.gov/books/NBK545190/

View request basketPrefer email? info@toxwriter.com
PDE / ADE derivationOEL derivationOEB / OHC banding
Assessment scope

PDE/ADE and OEL/OEB assessment

ToxWriter provides project-specific support for Insulin PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Insulin Permitted Daily Exposure (PDE) report (the Insulin PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Insulin Occupational Exposure Limit (OEL) report (the Insulin OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.

Assessment may cover

  • PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
  • OEL derivation considering relevant hazards, exposure route, duration and workplace conditions.
  • OEB/OHC banding where requested and supported by the evidence; an exposure band is not a numerical OEL.
  • Review of substance identity, evidence quality, uncertainty and data gaps.
PDE/ADE, OEL & OEB/OHC regulatory framework

The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.